Page 50 - FINAL PROGRAMME 2017

MONDAY, 3 JULY 2017
INVITED SESSION
08:30 - 09:30 Plenary 1
Session 01: Keynote session
Chairman: J. Evers (The Netherlands) Chairman: K. Lundin (Sweden)
08:30 O-001
Human Reproduction keynote lecture - Autologous cell therapy with CD133+ bone marrow- derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study
X. Santamaría1, I. Cervelló2, S. Cabanillas3, C. Arbona4, F. Raga5, J. Ferro6, J. Palmero7, J. Remohi8, A. Pellicer8, C. Simon9
1Fundacion Instituto Valenciano de Infertilidad FIVI. Valencia. Spain- Instituto Valenciano Infertilidad IVI, Obstetrics and Gynecology, Barcelona, Spain
2Fundacion Instituto Valenciano de Infertilidad FIVI, Research, Valencia, Spain 3Instituto Valenciano Infertilidad IVI, Obstetrics and Gynecology, Valencia, Spain 4Hospital Clinico Universitario/INCLIVA., Department of Hematology, Valencia, Spain 5Hospital Clinico Universitario/INCLIVA, Obstetrics and Gynecology, Valencia, Spain 6Instituto Valenciano Infertilidad IVI, Surgery, Valencia, Spain
7Hospital Clinico Universitario/INCLIVA, Department of Radiology, Valencia, Spain
8Instituto Valenciano Infertilidad IVI. School of Medicine. Valencia University and Instituto Universitario IVI/INCLIVA, Obstetrics and Gynecology, Valencia, Spain
9Fundacion Instituto Valenciano de Infertilidad FIVI. Spain- Instituto Valenciano Infertilidad IVI. Spain- Department of Obstetrics Gynecology. School of Medicine. Valencia University and Instituto Universitario IVI/INCLIVA. Spain- Department of Obste
Non-invasive prenatal testing (NIPT) - state of the art
Y.M.D. Lo1
1The Chinese University of Hong Kong, Li Ka Shing Institute of Health Sciences Prince of Wales Hospital, Shatin- New Territories, Hong Kong
09:00 O-002
50